Free Republic

It really spiraled into a long, arduous journey of learning what happens when big corporate interests overtake the needs of an individual," said Brianne Dressen. ... She struggled to survive a COVID vaccine clinical trial, but Brianne Dressen’s story led to a global movement and a historic court battle. ... In 2020, Dressen was a busy mom, a preschool teacher, and married to a PhD chemist. She volunteered to be part of the AstraZeneca COVID vaccine trial. “It just seemed like second nature to me. I was watching what was going on on the news. Medical professionals are in my...

Alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine are being probed, a contract company involved in the research has confirmed.Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson, who worked for the company during this time, told the British Medical Journal that the trial was riddled with issues, including the falsification of data.Jackson said she alerted the Food and Drug Administration (FDA) to the problems she witnessed and was fired within hours.Ventavia confirmed to The Epoch Times that it employed Jackson for two weeks last year. Lauren Foreman, director of...

“I’m delighted that today the first human trials of a vaccine against coronavirus are happening here in the UK,” Secretary of State for Health and Social Care Matt Hancock said in a video statement. Hancock, also an MP for West Suffolk, said officials “have all got our fingers crossed that this goes okay.” The vaccine candidate was developed by the University of Oxford, which didn’t immediately respond to a request for more information. Three lead researchers said in a statement Tuesday that the trial would start this week. The trial is being run by the Jenner Institute and Oxford Vaccine...

London — In the global scramble for a COVID-19 vaccine, a select number of human trials are now under way, but it's scientists from England's University of Oxford who appear most confident that they're onto a cure. Professor Sarah Gilbert heads the Oxford team behind the potential vaccine being developed in partnership with the Jenner Institute. She's said it has an "80% chance" of success, and it could be available for wide use by the public as soon as September. Human trials of the vaccine began Thursday in Oxford. It will be administered to 510 healthy volunteers between the ages...